AIM

AIM ImmunoTech Inc.

Healthcare · Biotechnology

$55.37 sample

+0.62 (+1.13%) 1D

Market cap

$109.2B

Price as of

2026-10-04

Latest filing

8-K · 2026-09-11

Alerts

8

Price$55.37 +14.99% 3M daily closessample

55.3747.91

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 28INSInsider sell: 10% owner
Sep 21INSInsider sell: Director
Sep 11SEC8-K filed: material event
Sep 04SEC8-K filed: material event
Aug 27INSInsider buy: 10% owner
Aug 20INSInsider sell: Chief Executive Officer
Aug 14SEC10-Q filed
Aug 07INSInsider buy: Director

Sign up to see the real AIM record →

Company facts

SEC EDGAR registration

Name: AIM ImmunoTech Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +28sample, -100 to +100
Reporting currency: USD

Who is positioning in AIM

sample

Insiders: 25 insider transactions over 90 days, net selling, $341.0M
Congress: 1 members traded over 90 days
Institutions · 13F: 23 funds hold $899.7M
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$4.7B +9.8% y/y

Q4 2024Q3 2026

Inventory$2.8B +14.5% y/y

Q4 2024Q3 2026

Accounts receivable$2.1B +7.8% y/y

Q4 2024Q3 2026

Total debt$5.5B +10.7% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $41.5B +8.5% 3M
Sample peer B: $57.6B +8.9% 3M
Sample peer C: $27.2B +8.9% 3M
Sample peer D: $34.6B -5.2% 3M
Sample peer E: $11.1B -0.1% 3M